Olio Labs
Combination therapeutics for the world's toughest diseases
Founded 2023 · $8.7M raised
- Employees
- 1–10
- Founded
- 2023
- Website
- oliolabs.co
- Total Funding
- $8.7M
- Last Round
- $4.5M Series AMar 2025
- Rounds
- 2
About
Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.
Summary
Olio Labs is a Healthcare company, founded in 2023. It has raised $8.7M in total across 2 rounds, most recently a $4.5M Series A round in Mar 2025. Investors include Y Combinator Continuity Fund, Boom Capital and Overwater Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...